Clinical Pharmacy Specialist, Hematology/Oncology/Cellular Therapy, Lymphoma Program and Lymphoma Translational Research
Hospital of the University of Pennsylvania
Mitchell E. Hughes, Pharm.D., BCOP is a hematology/oncology clinical pharmacy specialist with the Lymphoma Program at the Abramson Cancer Center at the Hospital of the University of Pennsylvania. He completed his pharmacy education at the Philadelphia College of Pharmacy, and then PGY-1 residency and PGY-2 hematology/oncology residency at the Hospital of the University of Pennsylvania. During his time at Penn Medicine, he works in an interdisciplinary environment in both clinical and research capacity. He has a number of publications and presentations in malignant and non-malignant diseases, including lymphoma, myeloma, CAR T-cell therapies, amyloidosis, PTLD, as well as oncology pharmacy practice topics. He is an active member of ASH, ACCP, ASHP and HOPA, a preceptor for PGY1 and PGY2 residents as well as local schools of pharmacy. Mitchell’s areas of interest include hematologic malignancies, cellular therapeutics, personalized diagnostics, and oral oncolytics.
Amyloidosis: Updates and Clinical Management
Tuesday, December 5, 2023
2:00 PM – 4:00 PM